- Home
- LOOP vs MNOV Comparison
LOOP vs MNOV Comparison
Compare LOOP & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOOP
- MNOV
- Stock Information
- Founded
- LOOP 2010
- MNOV 2000
- Country
- LOOP Canada
- MNOV United States
- Employees
- LOOP N/A
- MNOV N/A
- Industry
- LOOP Major Chemicals
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- LOOP Industrials
- MNOV Health Care
- Exchange
- LOOP Nasdaq
- MNOV Nasdaq
- Market Cap
- LOOP 72.5M
- MNOV 68.2M
- IPO Year
- LOOP N/A
- MNOV 2005
- Fundamental
- Price
- LOOP $1.53
- MNOV $1.35
- Analyst Decision
- LOOP
- MNOV Strong Buy
- Analyst Count
- LOOP 0
- MNOV 2
- Target Price
- LOOP N/A
- MNOV $7.00
- AVG Volume (30 Days)
- LOOP 94.4K
- MNOV 62.5K
- Earning Date
- LOOP 10-14-2025
- MNOV 08-14-2025
- Dividend Yield
- LOOP N/A
- MNOV N/A
- EPS Growth
- LOOP N/A
- MNOV N/A
- EPS
- LOOP N/A
- MNOV N/A
- Revenue
- LOOP $11,135,000.00
- MNOV $134,599.00
- Revenue This Year
- LOOP N/A
- MNOV N/A
- Revenue Next Year
- LOOP $777.41
- MNOV N/A
- P/E Ratio
- LOOP N/A
- MNOV N/A
- Revenue Growth
- LOOP 8335.61
- MNOV N/A
- 52 Week Low
- LOOP $0.85
- MNOV $1.13
- 52 Week High
- LOOP $2.29
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- LOOP 52.88
- MNOV 52.82
- Support Level
- LOOP $1.39
- MNOV $1.29
- Resistance Level
- LOOP $1.59
- MNOV $1.36
- Average True Range (ATR)
- LOOP 0.09
- MNOV 0.04
- MACD
- LOOP -0.01
- MNOV 0.00
- Stochastic Oscillator
- LOOP 48.28
- MNOV 60.00
About LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.